Copanlisib in patients with relapsed or refractory follicular lymphoma.

被引：4
|
作者：
Dreyling, Martin H.
Santoro, Armando
Leppa, Sirpa
Demeter, Judit
Follows, George
Lenz, Georg
Kim, Won Seog
Mollica, Luigina
Nagler, Arnon
Diong, Colin Phipps
Provencio, Mariano
Stevens, Don A.
Trevarthen, David
Magagnoli, Massimo
Cupit, Lisa
Yin, Shuxin
Hiemeyer, Florian
-Vargas, Jose E. Garcia
Childs, Barrett H.
Zinzani, Pier Luigi
机构：
[1] Univ Hosp LMU, Munich, Germany
[2] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Rozzano, Italy
[3] Helsinki Univ Cent Hosp, Canc Ctr, Helsinki, Finland
[4] Semmelweis Univ, Div Haematol, Dept Internal Med 1, Budapest, Hungary
[5] Cambridge Univ Hosp, Cambridge, England
[6] Munster Univ Clin, Translat Oncol Med Clin, Munster, Germany
[7] Sungkyunkwan Univ, Div Hematol & Oncol, Samsung Med Ctr, Sch Med, Seoul, South Korea
[8] Hop Maison Neuve Rosemont, Montreal, PQ, Canada
[9] Chaim Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel
[10] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore
[11] Univ Autonoma Madrid, Hlth Res Inst, Hosp Univ Puerta Hierro, Madrid, Spain
[12] Norton Canc Inst, Louisville, KY USA
[13] Comprehens Canc Care & Res Inst, Englewood, CO USA
[14] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA
[15] Bayer AG, Div Pharmaceut, Berlin, Germany
[16] Univ Bologna, Inst Hematol L eA Seragnoli, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.7535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7535
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Tazemetostat: a treatment option for relapsed/refractory follicular lymphoma
    Mondello, Patrizia
    Ansell, Stephen M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) : 295 - 301
  • [32] How I Treat Relapsed/Refractory Follicular Lymphoma
    Martin, Peter
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 2 - 5
  • [33] Emerging therapies for the treatment of relapsed or refractory follicular lymphoma
    MacDonald, D.
    Prica, A.
    Assouline, S.
    Christofides, A.
    Lawrence, T.
    Sehn, L. H.
    CURRENT ONCOLOGY, 2016, 23 (06) : 407 - 417
  • [34] Axicabtagene ciloleucel for the treatment of relapsed or refractory follicular lymphoma
    Cohen, Jared A.
    Ghobadi, Armin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (09) : 903 - 914
  • [35] Unmet Needs in the Management of Relapsed or Refractory Follicular Lymphoma
    Burke, John M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (12) : 3 - 10
  • [36] Prognostic Factors of Autologous Transplantation in the Treatment of Patients With Relapsed/Refractory Follicular Lymphoma
    Jona, Adam
    Kenyeres, Anna
    Kiss, Evelin
    Illes, Arpad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S384 - S385
  • [37] Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
    Angelopoulou, Maria K.
    Vassilakopoulos, Theodoros P.
    Batsis, Ioannis
    Sakellari, Ioanna
    Gkirkas, Konstantinos
    Pappa, Vasiliki
    Giannoulia, Panagiota
    Apostolidis, Ioannis
    Apostolopoulos, Christos
    Roussou, Paraskevi
    Panayiotidis, Panayiotis
    Dimou, Maria
    Kyrtsonis, Marie-Christine
    Palassopoulou, Maria
    Vassilopoulos, Georgios
    Moschogiannis, Maria
    Kalpadakis, Christina
    Margaritis, Dimitrios
    Spyridonidis, Alexander
    Michalis, Eurydiki
    Anargyrou, Konstantinos
    Repousis, Panagiotis
    Hatzimichael, Eleutheria
    Bousiou, Zoi
    Poulakidas, Elias
    Grentzelias, Dimitrios
    Harhalakis, Nikolaos
    Pangalis, Gerassimos A.
    Anagnostopoulos, Achilles
    Tsirigotis, Panagiotis
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 174 - 181
  • [38] Response to short course ESHAP chemotherapy in relapsed and refractory lymphoma.
    Robinson, SP
    Addada, J
    Green, N
    Wong, WL
    Shaw, P
    Chakraverty, R
    Goldstone, AH
    Macmillan, A
    Linch, DC
    BLOOD, 2000, 96 (11) : 246B - 246B
  • [39] A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma
    Qualls, David
    Lam, Hiu Ying
    Whiting, Karissa
    Kumar, Anita
    Matasar, Matthew
    Owens, Colette
    Nichols, Chelsea
    Espeleta, James A.
    Qiu, Annie
    Subzwari, Sarima
    Biggar, Erin
    Seshan, Venkatraman
    Salles, Gilles
    Younes, Anas
    Batlevi, Connie
    BLOOD ADVANCES, 2022, 6 (18) : 5262 - 5266
  • [40] An open-label phase II study of ibrutinib in patients with refractory follicular lymphoma.
    Salles, Gilles A.
    Gopal, Ajay K.
    Martin, Peter
    Marcus, Robert
    Hess, Georg
    Zinzani, Pier Luigi
    Ahmadi, Tahamtan
    Zhuang, Sen Hong
    Levy, Ronald
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345